Document Detail


Dabigatran etexilate: advances in anticoagulation therapy.
MedLine Citation:
PMID:  20528634     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
EVALUATION OF: Schulman S, Kearon C, Kakkar AK et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N. Engl. J. Med. 361, 2342-2352 (2009). Venous thromboembolism (VTE) is associated with significant morbidity and mortality. The need for anticoagulation therapy is well recognized, but treatment is frequently suboptimal owing to limitations of current agents. The RE-COVER trial compared 150 mg twice-daily dabigatran etexilate (herafter referred to as dabigatran) with warfarin for 6 months in patients with acute VTE; dabigatran was as effective as warfarin in preventing recurrent VTE, with comparable major bleeding and significantly lower total bleeding rates. The Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial on stroke prevention in patients with atrial fibrillation has also been completed recently, and dabigatran at higher doses showed superior efficacy in preventing stroke and systemic embolism, with lower bleeding than warfarin. Dabigatran provides convenient fixed-dose treatment without the need for monitoring, and has the potential to change the management of venous and arterial thromboembolism.
Authors:
Ola E Dahl; Menno V Huisman
Related Documents :
11202464 - Warfarin therapy and cataract surgery.
8696894 - The long-term outcome of proximal vein thrombosis during pregnancy is not improved by t...
4049314 - A multicenter study on amidolytic factor x evaluation in oral anticoagulant therapy.
8173144 - Monitoring warfarin therapy with the international normalized ratio.
22535804 - Pyogenic discitis following discectomy.
6493504 - Response variations in the treatment of parkinson's disease.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  8     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-09     Completed Date:  2010-10-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  771-4     Citation Subset:  -    
Affiliation:
Department of Orthopaedics, Elverum Central Hospital, Elverum, Norway. olaedahl@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Comment On:
N Engl J Med. 2009 Dec 10;361(24):2342-52   [PMID:  19966341 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contemporary management of patients with Type 2 diabetes.
Next Document:  Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular eff...